This excerpt from the 3D animation created for BTG’s interventional oncology drug called DC Bead®, explains how chemoembolization (also called transartertial chemoembolization or TACE) is used in the treatment of Primary liver cancer / hepatocellular carcinoma (HCC) with the use of drug-eluting beads.
Our brief was to develop a modern and stylish vision of Biocompatibles' DC bead product animation. We achieved this and through effective storytelling showcased the mechanism-of-action (MoA) of DC Bead® -- how the drug is administered to patients via a minimally invasive procedure and how it effectively embolizes the tumor in the liver. The use of motion graphics aid in highlighting the clinical findings and evidence-based research data from scientific experts, and compliments the messaging of the MoA.